James Sherblom serves as Executive at Comera Life Sciences Holdings, Inc., where they oversee executive responsibilities. Since joining the company, James Sherblom has executed 3 insider transactions totaling $201.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 4, 2023 involved receiving (via award) 81,081 shares valued at $99.7K.
James Sherblom currently holds 452,244 shares of Comera Life Sciences Holdings, Inc. (CMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Sherblom has been a net buyer of CMRA stock. They have purchased $201.2K and sold $0 worth of shares.
James Sherblom's most recent insider trade was on Jan 4, 2023, when they sold 81,081 shares at $1.23 per share.
Get notified when new Form 4 filings are submitted
| $1.23 |
| Discretionary |
| Sep 12, 2022 | CMRA | $101.5K | Purchase | 50,000 | $2.03 | Discretionary |